Table 1. Baseline characteristics.
Variables | Sub-group | Value (n = 63) |
---|---|---|
Age (year): median (IQR) | 8 (6–10) | |
< 4 years | 7 (11.11%) | |
4–9 years | 33 (52.38%) | |
10–13 years | 23 (36.51%) | |
Sex | Female | 33 (52.38%) |
BCG Vaccination | Received | 51 (80.95%) |
Not Received | 3 (4.76%) | |
Undocumented | 9 (14.29%) | |
BCG Scar | Present | 45 (71.43%) |
Absent | 18 (28.57%) | |
History of TB more than 2 years | Yes | 8 (12.7%) |
No | 55 (87.30%) | |
Type of previous TB | 1 (12.5%) | |
3 (37.5%) | ||
2 (25%) | ||
2 (25%) | ||
TB exposure | 10 (15.87%) | |
10 (100%) | ||
0 | ||
People exposed to TB at home | 6 (60%) | |
4 (40%) a | ||
Malnutrition (WA Z score< –2) | 26 (41.27%) | |
WHO HIV clinical staging: | ||
Stage I | 5 (7.9%) | |
Stage II | 15 (23.8%) | |
Stage III | 37 (58.73%) | |
Stage IV | 6 (9.52%) | |
Patients on ARV treatment at inclusion | 33 (52.38%) | |
Frequency of TB confirmed to bacteriology children confirmed TB to bacteriology: | 31 (49.2%) 13 (41.93%) | |
PTB+ | ||
PTB- | ||
Extra pulmonary TB | ||
Undocumented | ||
Total | ||
At home | ||
Away from home | ||
Mother | ||
Other person |
BCG: Bacille Calmette Guérin; TB: Tuberculosis; PTB+: Microscopic positive pulmonary tuberculosis; PTB-: Microscopic negative pulmonary tuberculosis, WA Z score: Weigh for age Z score; WHO: World Health Organization; HIV: Human Immuno-Deficiency Virus, ARV: Anti-retroviral, IQR: Inter quartile interval.